The United Kingdom's Medicines and Healthcare Products Regulatory Agency strengthened its warnings on GLP-1 receptor agonists ...

Learn about the global clinical trial for sickle cell disease aimed at improving quality of life and addressing anemia.

Jay Bhattacharya, the N.I.H. director, says authorities broke the public’s trust in the Covid era. Now it’s up to outsiders to restore it.

A Black female doctor when that was rare, she developed a diagnostic test for the disease that is still a standard tool, as well as treatment guidelines.

The COVID-19 pandemic gave us tremendous perspective on how wildly symptoms and outcomes can vary between patients ...